A statistically defined endpoint titer determination method for immunoassays.
about
Antibody to aquaporin 4 in the diagnosis of neuromyelitis opticaA novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced diseaseDescription of a nanobody-based competitive immunoassay to detect tsetse fly exposureIntradermal electroporation of naked replicon RNA elicits strong immune responsesADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challengeUsing high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infectionIn vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine.Molecular evolution of peptide ligands with custom-tailored characteristics for targeting of glycostructuresNear-infrared laser adjuvant for influenza vaccineNovel Anti-Nicotine Vaccine Using a Trimeric Coiled-Coil Hapten CarrierFrequent and seasonally variable sublethal anthrax infections are accompanied by short-lived immunity in an endemic systemEvaluating the frequency of asymptomatic Ebola virus infectionProtective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine.An Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman Primates.In Vivo Analysis of the Potency of Silicone Oil Microdroplets as Immunological Adjuvants in Protein FormulationsSilicone Oil Microdroplets Can Induce Antibody Responses Against Recombinant Murine Growth Hormone in Mice.Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy.Reduced pathology and improved behavioral performance in Alzheimer's disease mice vaccinated with HSV amplicons expressing amyloid-beta and interleukin-4.Analysis of liquid bead microarray antibody assay data for epidemiologic studies of pathogen-cancer associations.Expression and serological application of a capsid protein of an iridovirus isolated from rock bream, Oplegnathus fasciatus (Temminck & Schlegel).Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccinePrevalence and serological diagnosis of relapse in paracoccidioidomycosis patients.Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosageEpitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease.Ebola exposure, illness experience, and Ebola antibody prevalence in international responders to the West African Ebola epidemic 2014-2016: A cross-sectional study.VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.Chlamydial protease-like activity factor mediated protection against C. trachomatis in guinea pigsAn ELISA assay using a combination of recombinant proteins from multiple strains of Orientia tsutsugamushi offers an accurate diagnosis for scrub typhusUltrarapid Measurement of Diagnostic Antibodies by Magnetic Capture of Immune ComplexesExpression profile of human immune-responsive gene 1 and generation and characterization of polyclonal antiserum.Combination of poly I:C and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo.Antibody responses against xenotropic murine leukemia virus-related virus envelope in a murine model.Virulence and immunity orchestrated by the global gene regulator sigL in Mycobacterium avium subsp. paratuberculosis.Study of the IgG endoglycosidase EndoS in group A streptococcal phagocyte resistance and virulence.Immunoglobulin E antileishmanial antibody response in cutaneous leishmaniasis.Chlamydial serology: comparative diagnostic value of immunoblotting, microimmunofluorescence test, and immunoassays using different recombinant proteins as antigens.Recombinant murine growth hormone particles are more immunogenic with intravenous than subcutaneous administrationGeographic separation of domestic and wild strains of Toxoplasma gondii in French Guiana correlates with a monomorphic version of chromosome1a.Sensitive detection of botulinum neurotoxin types C and D with an immunoaffinity chromatographic column testAntibody response of definitive hosts against antigens of two life stages of the neuropathogenic schistosome Trichobilharzia regenti
P2860
Q21144670-CF67E655-B3DE-470C-9DC2-0E09F17E9CA6Q21560951-043B61EE-D44F-485A-9285-89C9463C7704Q27304633-912492A6-599E-4630-B081-0FD06F13BC03Q27310340-7D19FEDD-3940-487B-92C6-4E3DCB362336Q27342615-9CD0A9E6-F2D8-4E34-ADE2-DEE45BE51818Q27488247-B275003C-CDC1-43B1-91B9-F38257DE63EBQ27901935-CFEA09BD-D54D-4055-B453-4A41EFAB71ABQ28484348-A7DCD32B-0224-48C4-A160-BFCD64F58BDDQ28536886-51F130B6-E9FE-4107-9E19-B18AA7ECC0AFQ28542642-D43A6624-7F24-465C-BCB6-102CF7776908Q28654914-5998BDAB-012C-4CC5-A29F-B961E7E4F466Q30251098-A11503BC-9183-486D-BFBA-86C534656DA4Q30360232-C1D514C8-81CF-4EAA-AD27-DB6A8FF56623Q30375785-B2EDF6F4-6C3D-4A78-A199-D8A4FB22CE2FQ30376902-ADDC092E-3995-4892-9905-C3C8C8142E2AQ30386156-D311521D-22CF-4D17-9F90-401C7EE761BFQ30423178-8A697353-C219-4CCD-A27D-8BE273B8A4ACQ30482492-C9E4B481-B010-4290-9D3C-A15362BC7BBDQ30970993-72273B72-E9C7-4FDC-B602-A03652075ACFQ33303763-B1B7D55F-F1CA-4DDB-B060-5F3B9B362AC5Q33359620-F5667653-3799-4A61-8229-96F437B139F6Q33552981-8458B195-7A4C-4366-9FA6-16CCA1593675Q33595830-FBC9B046-49F6-472C-A028-CEFC0011B89DQ33631871-2A13BB41-4CD6-4201-9088-FB067B998EC1Q33693686-0BD3C4D6-20B1-490C-8517-87F6FABD84C8Q33723534-AF121F6A-72E5-4A7C-B46E-53C14E06B24FQ33740057-B999D23B-86C0-4076-8A94-01BB17E2DE4AQ33785107-A6BC7BE9-284C-44FC-BF44-38480F0FE1A6Q33812635-740031AF-8E4A-4E19-B633-F41E06833B4DQ33851955-BBD29C42-5FF6-4326-8C0F-E9A4F344AABBQ33853324-9101168B-141B-4E9C-8784-2F826FAED3F5Q33873719-838C45AD-BC7F-416C-9C25-7A0D1C08CA78Q33899751-286442FA-600F-4733-8D87-5B60B6AB842DQ33914405-A7827DCB-4EDC-4106-B8E9-75007EE2B135Q33941407-09544802-59D0-4C17-A5A2-609D286E1F20Q33971892-812970AA-A71D-4559-B156-C93D2A7D78CBQ34064079-437C9E15-1CDB-455E-A215-E7C77EA99528Q34213936-8717876B-B07A-4769-9136-905D4353C85BQ34232837-F39DB1F7-A6BC-4983-AE1C-497B5FDC18ADQ34487142-75DD3FEE-B3EE-49B8-86A2-D64F2231B869
P2860
A statistically defined endpoint titer determination method for immunoassays.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
A statistically defined endpoint titer determination method for immunoassays.
@en
A statistically defined endpoint titer determination method for immunoassays.
@nl
type
label
A statistically defined endpoint titer determination method for immunoassays.
@en
A statistically defined endpoint titer determination method for immunoassays.
@nl
prefLabel
A statistically defined endpoint titer determination method for immunoassays.
@en
A statistically defined endpoint titer determination method for immunoassays.
@nl
P2093
P1476
A statistically defined endpoint titer determination method for immunoassays.
@en
P2093
P356
10.1016/S0022-1759(98)00170-7
P577
1998-12-01T00:00:00Z